Australia's Resonance Health jumps on over 3-fold rise in FY24 earnings
** Shares of Resonance Health RHT.AX rise as much as 21.2%
to A$0.063; set to gain most since Apr. 8
** The MedTech co posts operating EBITDA of A$1.12 mln
($761,376.00) for FY24, up 234% YoY
** Adds revenue up 95% YoY
** RHT has gained ~7% this week, on track for its best week
since week ending Aug. 2
** Stock down over 13% so far this year
($1 = 1.4710 Australian dollars)
(Reporting by Rajasik Mukherjee in Bengaluru)
((Rajasik.Mukherjee@thomsonreuters.com;))
Recent news on Resonance Health
See all newsBrief: Resonance Health Halts Trading In Resonance Health Securities Pending Announcement
Australia's Resonance Health gains on IAG agreement
Brief: Resonance Health Enters Global Strategic Alliance & MSA With Image Analysis Group
Brief: Resonance Health Posts Profit Attributable Of A$1.5 Million
Brief: Resonance Health Says It Expects FY27 Normalised EBITDA Of AUD 2.6 To 3.6 Million